Literature DB >> 22194210

Key pathways involved in prostate cancer based on gene set enrichment analysis and meta analysis.

Q Y Ning1, J Z Wu, N Zang, J Liang, Y L Hu, Z N Mo.   

Abstract

Prostate cancer is one of the most common male malignant neoplasms; however, its causes are not completely understood. A few recent studies have used gene expression profiling of prostate cancer to identify differentially expressed genes and possible relevant pathways. However, few studies have examined the genetic mechanics of prostate cancer at the pathway level to search for such pathways. We used gene set enrichment analysis and a meta-analysis of six independent studies after standardized microarray preprocessing, which increased concordance between these gene datasets. Based on gene set enrichment analysis, there were 12 down- and 25 up-regulated mixing pathways in more than two tissue datasets, while there were two down- and two up-regulated mixing pathways in three cell datasets. Based on the meta-analysis, there were 46 and nine common pathways in the tissue and cell datasets, respectively. Three up- and 10 down-regulated crossing pathways were detected with combined gene set enrichment analysis and meta-analysis. We found that genes with small changes are difficult to detect by classic univariate statistics; they can more easily be identified by pathway analysis. After standardized microarray preprocessing, we applied gene set enrichment analysis and a meta-analysis to increase the concordance in identifying biological mechanisms involved in prostate cancer. The gene pathways that we identified could provide insight concerning the development of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22194210     DOI: 10.4238/2011.December.14.10

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  6 in total

1.  Metabolomic profiling identifies biochemical pathways associated with castration-resistant prostate cancer.

Authors:  Akash K Kaushik; Shaiju K Vareed; Sumanta Basu; Vasanta Putluri; Nagireddy Putluri; Katrin Panzitt; Christine A Brennan; Arul M Chinnaiyan; Ismael A Vergara; Nicholas Erho; Nancy L Weigel; Nicholas Mitsiades; Ali Shojaie; Ganesh Palapattu; George Michailidis; Arun Sreekumar
Journal:  J Proteome Res       Date:  2013-12-31       Impact factor: 4.466

2.  Regulators of gene expression as biomarkers for prostate cancer.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

3.  A novel microRNA signature predicts survival in stomach adenocarcinoma.

Authors:  Bowen Ding; Xujie Gao; Hui Li; Liren Liu; Xishan Hao
Journal:  Oncotarget       Date:  2017-04-25

4.  RTK/ERK pathway under natural selection associated with prostate cancer.

Authors:  Yang Chen; Xianxiang Xin; Jie Li; Jianfeng Xu; Xiaoxiang Yu; Tianyu Li; Zengnan Mo; Yanling Hu
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

5.  Identification of key target genes and pathways in laryngeal carcinoma.

Authors:  Feng Liu; Jintao Du; Jun Liu; Bei Wen
Journal:  Oncol Lett       Date:  2016-06-17       Impact factor: 2.967

6.  Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progression.

Authors:  Yang Chen; Qin Zhang; Qiuyan Wang; Jie Li; Csilla Sipeky; Jihan Xia; Ping Gao; Yanling Hu; Haiying Zhang; Xiaobo Yang; Haitao Chen; Yonghua Jiang; Yuehong Yang; Ziting Yao; Yinchun Chen; Yong Gao; Aihua Tan; Ming Liao; Johanna Schleutker; Jianfeng Xu; Yinghao Sun; Gong-Hong Wei; Zengnan Mo
Journal:  Sci Rep       Date:  2017-07-03       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.